Skip to main content

Journal Club - October 28, 2021

IAMI Trial

Dr. Kurt Hoskin presented the IAMI Trial, which is an investigator-initiated, randomized, double-blind trial to compare inactivated influenza vaccine with saline placebo administered shortly after myocardial infarction or high-risk stable coronary heart disease. The primary endpoint was the composite of all-cause death, MI, or stent thrombosis at 12 months. The trial was published in Circulation in August of this year and presented at ESC.

CCI is an inclusive centre with multidisciplinary membership for all cardiovascular investigators in BC